Enanta Pharmaceuticals (ENTA) EBT Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 29.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.67% |
| Dec 31, 2025 | 25.68% |
| Sep 30, 2025 | 10.84% |
| Jun 30, 2025 | 17.23% |
| Mar 31, 2025 | 10.67% |
| Dec 31, 2024 | 9.02% |
| Sep 30, 2024 | 4.39% |
| Jun 30, 2024 | 11.63% |
| Mar 31, 2024 | -2.63% |
| Dec 31, 2023 | -43.06% |
| Sep 30, 2023 | -16.57% |
| Jun 30, 2023 | -17.63% |
| Mar 31, 2023 | -55.91% |
| Dec 31, 2022 | -57.96% |
| Sep 30, 2022 | -71.28% |
| Jun 30, 2022 | -93.19% |
| Mar 31, 2022 | -235.31% |
| Dec 31, 2021 | -44.45% |
| Sep 30, 2021 | -43.11% |
| Jun 30, 2021 | -50.27% |
| Mar 31, 2021 | -53.64% |
| Dec 31, 2020 | -40.23% |
| Sep 30, 2020 | -32.74% |
| Jun 30, 2020 | -19.55% |
| Mar 31, 2020 | -3.48% |
| Dec 31, 2019 | 62.51% |
| Sep 30, 2019 | 74.49% |
| Jun 30, 2019 | 126.44% |
| Mar 31, 2019 | 129.69% |
| Dec 31, 2018 | -6.10% |
| Sep 30, 2018 | 104.70% |
| Jun 30, 2018 | 129.26% |
| Mar 31, 2018 | -28.37% |
| Dec 31, 2017 | -39.86% |
| Sep 30, 2017 | 133.90% |
| Jun 30, 2017 | -33.11% |
| Mar 31, 2017 | -19.85% |
| Dec 31, 2016 | -6.69% |
| Sep 30, 2016 | 16.06% |
| Jun 30, 2016 | 46.27% |
| Mar 31, 2016 | 71.37% |
| Dec 31, 2015 | 17.87% |
| Sep 30, 2015 | 44.73% |
| Jun 30, 2015 | 37.01% |
| Mar 31, 2015 | 14.95% |